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Neutrophils releasing neutrophil extracellular traps (NETs) infiltrate the pancreas prior to
type 1 diabetes (T1D) onset; however, the precise nature of their contribution to disease
remains poorly defined. To examine how NETs affect immune functions in T1D, we
investigated NET composition and their effect on dendritic cells (DCs) and T lymphocytes
in T1D children. We showed that T1D patient NET composition differs substantially from
that of healthy donors and that the presence of T1D-NETs in a mixed peripheral blood
mononuclear cell culture caused a strong shift toward IFNγ-producing T lymphocytes,
mediated through activation of innate immunity cells in T1D samples. Importantly, in a
monocyte-derived DC (moDC) culture, NETs induced cytokine production, phenotypic
change and IFNγ-producing T cells only in samples from T1D patients but not in those
from healthy donors. RNA-seq analysis revealed that T1D-NETs presence causes TGFβ
downregulation and IFNα upregulation and creates pro-T1D signature in healthy moDCs.
Keywords: NET, netosis, type 1 diabetes, monocyte-derived dendritic cells, innate immunity, autoimmunity,
neutrophils
INTRODUCTION
Type 1 diabetes (T1D) is generally viewed as a Th1-mediated autoimmune disease in which
cytotoxic T lymphocytes attack insulin-producing beta cells in pancreatic islets. However,
infiltrating autoreactive T lymphocytes represent only one part of a more complex network of
immune cells located in the pancreatic islets during the development of T1D. Macrophages,
dendritic cells (DC) and natural killer cells have all been well documented to play crucial roles in
T1D pathogenesis (1). Neutrophils infiltrate the islets prior to the onset of T1D symptoms as well
as during disease progression (2), but the precise role of neutrophils, which are the most plentiful
leukocytes and first responders during inflammation, remains elusive (3).
Apart from the classic defense mechanisms that neutrophils possess, such as phagocytosis,
reactive oxygen species (ROS) production and granule degranulation, neutrophils might also
form extracellular networks known as NETs (neutrophil extracellular traps). They are released
to trap, neutralize, and kill bacteria (4), viruses (5) and fungi (6). NETs are large, extracellular,
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web-like structures composed of cytosolic and granule proteins
that are assembled on decondensed chromatin (4). Notably,
NETs represent endogenous danger signals that are sufficient to
initiate inflammation in the absence of microbial priming and
can potentiate the resolution of inflammation. NETs escalate
inflammation through the regulation of inflammatory cytokines
directly or indirectly by modulating and activating other immune
cells (7, 8).
However, NETs are also a source of autoantigens and
can contribute to the pathogenesis of some autoimmune
diseases, particularly those associated with autoantibodies against
neutrophil-derived proteins such as antineutrophil cytoplasmic
antibody (ANCA) – associated vasculitis (9). In systemic lupus
erythematosus (SLE), NETs can activate plasmacytoid dendritic
cells (pDCs) and trigger type I interferon (IFN) production and
drive autoimmune pathology (10, 11).
Little is known about the involvement of NETs in T1D.
Although controversial opinions emerged about the presence
of NET-related biomarkers in the peripheral blood at T1D (12,
13), neutrophils releasing NETs have been clearly shown to be
present in the pancreas of pre-symptomatic and symptomatic
T1D patients, and it is thus safe to assume they may play a
role in the initiation of beta cell destruction (2, 14). In addition,
high glucose levels were reported to impair and delay NET
release in diabetic patients, providing a contributing mechanism
for the increased susceptibility to infections and wound healing
impairment of diabetic patients (15, 16). In contrast, other reports
have shown that neutrophils from patients with diabetes release
NETs more readily, which may be linked to an elevated glucose
level (17–19).
Therefore, we initiated a study of NETs in pediatric T1D
patients, aiming to evaluate the differences in NET composition,
their effect on antigen presenting cell phenotype, cytokine
production and subsequent induction of T cell differentiation.
PATIENTS AND METHODS
Patients
Written informed consent was obtained from all the patients
or the patients’ parents/guardians in accordance with the
Declaration of Helsinki, and the study was approved by the Ethics
Committee of University Hospital Motol.
A cohort of 45 pediatric patients with T1D (59% female) and
30 healthy donors (48% female) was included in this study. The
median age of patients with T1D was 15.5 ± 2 years (range:
11.2–18.6 years) and of the healthy donors was 18.5 ± 2.9 years
(range: 12.2–21.6 years). All patients with T1D were treated
with insulin since disease onset. The median T1D duration was
6.7 ± 3.7 years (range: 1.1–15.3 years). The median of their last
glycated hemoglobin (HbA1c) was 61 ± 12 mmol/mol (range:
39–87 mmol/mol). At the time of blood sampling, patients were
metabolically stable; none of them had signs of active infection,
neoplasia or other comorbidities except well-controlled celiac
disease or autoimmune thyroiditis (11% of recruited patients with
T1D). The healthy donors had a negative personal history of
autoimmune diseases.
Cell Isolation and Culture
Peripheral blood was collected from patients and healthy
volunteers into EDTA-coated tubes. First, peripheral blood
mononuclear cells (PBMCs) were isolated using Ficoll-Paque
(GE Healthcare Bio-Sciences, Uppsala, Sweden). Neutrophils
were further isolated using the Dextran sedimentation method,
remaining red blood cells were hypotonically lysed and
granulocytes were washed twice in PBS without EDTA.
Neutrophil purity was < 95%, the major contaminants
were eosinophils. The obtained cells were resuspended in
RPMI 1640 medium with sodium bicarbonate buffer system,
supplemented with 2% autologous serum, 1% penicillin and
streptomycin and 1% Glutamax (Thermo Fisher Scientific,
Waltham, MA, United States).
NET Induction
NET formation was induced according a protocol adapted
from (7). Briefly, the isolated neutrophils were plated in 6-
well plates at a density of 106 cells/ml and stimulated with
50 nM phorbol myristate acetate (PMA) (20, 21) (Cayman
Chemicals, Ann Arbor, United States) for 3 h in 37◦C in 5%
CO2 to maintain physiological pH. The culture medium was
then carefully removed; the NETs were carefully washed with
PBS to remove possible products of neutrophil activation or
degranulation and then partially digested by a restriction enzyme
mix containing enzymes AluI, NdeI and PacI (all from Thermo
Fisher Scientific) at a concentration of 10 U/ml in complete
media supplemented with 2% autologous serum. The digest was
performed at 37◦C for 20 min, followed by centrifugation at
12,000× g for 10 min to remove cells and debris. The NET-DNA
concentration was determined on a Nanodrop (Thermo Fisher
Scientific). NET-containing supernatants were then characterized
for their DNA and protein content using several approaches.
The size of the DNA fragments was analyzed by electrophoresis.
For western blot analysis, membranes with loaded samples
were incubated with the primary antibodies anti-PR3 (Abcam,
Cambridge, United Kingdom) overnight, followed by incubation
with peroxidase-conjugated anti-rabbit or anti-mouse secondary
antibodies for 2 h. The membranes were developed using
SuperSignal West Femto (Thermo Fisher Scientific).
NET-Associated Products Quantification
Isolated neutrophils were seeded at a concentration of 2 × 106
cells/ml, stimulated with 50 nM PMA, washed, digested with
S7 nuclease (Cayman Chemicals) for 20 min, centrifuged and
stored at −20◦C. Neutrophil elastase, myeloperoxidase (both
from Abcam), LL37 (Hycult Biotech, Wayne, NJ, United States)
and DNA-histone associated complex (Sigma-Aldrich, St. Luis,
United States) concentrations were evaluated by ELISA. The
DNase I concentration in the human serum was also determined
by ELISA (LifeSpan BioSciences, Seattle, WA, United States).
T Cell Induction
Peripheral blood mononuclear cells at a concentration of 106
cells/ml were co-cultured with 1,000 ng/ml of autologous NET
fragments for 7 days. On day 7, IFNγ- and IL-17-producing T
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cells were stained according to a previously published protocol
(22). For T regulatory lymphocyte determination, we used a
previously published staining protocol (23).
Generation of Monocyte-Derived
Dendritic Cells and Co-culture With NETs
Monocyte-derived DCs were generated from adherent
monocytes according to a protocol published previously (24).
Immature dendritic cells (iDC) were seeded at a concentration
of 106 cells/ml with or without 1,000 ng/ml NETs from the same
donor. After 24 h, moDCs were stained with antiCD11c-APC
and CD14-PEDy590 (Exbio), CD80-FITC (Beckman Coulter)
as well as CD86-PECY5, HLA-DR-PECY7 (both from BD
Bioscience), PDL1-PE (BioLegend) and DAPI (Thermo Fisher
Scientific). The viability of the moDCs was estimated as DAPI
negative for CD11c positive moDCs. The samples were collected
using a BD FACSAria II (BD Biosciences), and BD FACSDiva
software (BD Biosciences) was used for signal acquisition.
moDC-T Cell Cultures
The capacity of iDC and iDC-NETs to activate T lymphocytes was
evaluated with autologous DC-T cell cultures. The assays were
carried out in media containing 5% human AB serum for 7 days
at a 1:5 DC:T cell ratio. IL-2 (20 U/ml) was added on days 2 and
5. On day 7, Treg expansion and IFNγ and IL-17 production was
analyzed as described in section T cell induction.
Cytokine Production
For the detection of cytokine production, 106 cells/ml moDCs
were cultured in a 96-well plate and stimulated with autologous
1,000 ng/ml NETs for 24 h and the cytokine levels in the culture
supernatants were determined by multiplex Luminex cytokine
bead-based immunoassay (Millipore, Bedford, United States).
L-Lactate Quantification
The concentration of L-lactate in PBMC and moDC culture
supernatants was measured with a glycolysis cell-based assay kit
(Cayman Chemicals).
RNA-Seq
106 moDC/ml from HD (healthy donors) were cultivated
with 1,000 ng/ml of autologous HD-NETs, with T1D-NETs or
left untreated for 8 h. Similarly, 106 moDCs/ml from T1D
were also cultivated with 1,000 ng/ml of autologous T1D-
NETs, HD-NETs or left untreated for 8 h. The cells were
then washed and lysed using RLT buffer (Qiagen, Hilden,
Germany). Total RNA was isolated using RNeasy Mini Kit
following manufacturer’s instructions (Qiagen), RNA quality and
quantification was determined by TapeStation 4200 (Agilent, St.
Clara, CA, United States) following manufacturer’s instructions.
Library construction was conducted employing the Illumina
True Seq stranded mRNA Poly A protocol and subsequently
sequenced using a HiSeq 4,000 (1 × 50bp single end reads,
15 samples per lane) following the manufacturer’s guidelines.
This resulted in approximately 21 million reads before and 17
million reads per sample after mapping. RNAseq reads were
trimmed for adapters using cutadapt (version 1.8.1) (25) while
low quality signals were removed using the fastq illumina filter1.
Resulting reads shorter than 50bp were omitted from further
analysis. Subsequent mapping to the human reference genome
GRCh38 was performed using TopHat (version 2.0.14) (26). Gene
expression counts were quantified using HTSeq (27). Differential
expression was determined by employing a Mann-Whitney-U
test, followed by estimating a false discovery rate based on a
Westfall & Young permutation (with k = 5,000 permutations)
as previously published (28). Only genes with a p-value ≤ 0.05
and a FDR ≤ 5% were considered differentially expressed. Data
is available from NCBI Gene Expression Omnibus (GEO) with
accession number GSE143143.
Statistical Analysis
The results obtained from at least three independent experiments
are given as the means ± SDs. Not all patients were involved
in all experiments due to the limited amount of blood available
per sample. Statistical analysis was performed using non-
parametric one-way analysis of variance (ANOVA) with multiple
comparisons Dunn’s post-test where applicable. A two-tailed
paired Wilcoxon or unpaired Mann-Whitney t-test was also
applied for data analysis using GraphPad Prism 8. Values of
p < 0.05 (∗), p < 0.01 (∗∗) p < 0.001 (∗∗∗) and p < 0.0001 (∗∗∗∗)
were considered statistically significant.
RESULTS
The Presence of T1D Patient NETs
Induces IFNγ-Producing T Cells in vitro
To estimate the biologic impact of NETs on T cells, the canonical
inducers of T1D, we co-cultured PBMCs with 1,000 ng/ml
autologous NET fragments and then evaluated the delineation of
T cell populations into Th1 cells (IFNγ-producing CD4 T cells),
Th17 cells (IL-17A-producing CD4 T lymphocytes), T regulatory
lymphocytes (Treg, FoxP3+CD25hiCD127− CD4 T cells) and
IFNγ-producing CD8 lymphocytes. The gating strategies are
illustrated in Supplementary Figures 1A, B. We obtained NET
fragments by stimulating neutrophils isolated from the peripheral
blood of T1D patients and healthy control donors with PMA for
3 h, cleaved the NETs with a restriction enzyme mix and used the
components consisting of large DNA fragments (Supplementary
Figure 1C) and NET-associated proteins, such as proteinase 3
(PR3) (Supplementary Figure 1D), for co-cultures and further
composition analysis.
T1D patients NETs induced a strong shift toward
IFNγ-producing CD4+ and CD8+ cells in autologous T
lymphocytes, which was also accompanied by an increase
in Tregs but not IL-17A-producing Th17 lymphocytes
(Figures 1A–D). In the control culture where healthy cells were
treated with their own healthy NETs, there was no significant
enrichment of any of these populations, but expression of CD25,
an important marker of Treg function, was increased on Tregs
1https://emea.illumina.com/products/by-type/informatics-products/basespace-
sequence-hub/apps/fastq-toolkit.html
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FIGURE 1 | Shift in T lymphocyte populations. Populations of (A) Th1 (IFNγ+CD4), (B) IFNγ-producing CD8+ lymphocytes, (C) Th17 (IL-17+CD4), (D) T regulatory
lymphocytes (Tregs) (CD4+FoxP3+CD25hiCD127-) with (E) CD25 expression on their surface were analyzed by flow cytometry in cultures from 20 T1D patients
(55% female) and 12 healthy donors (50% female) after 7 day cultivation with or without autologous NET fragments. (F) Induction of Th1, Th17, Treg, and IFNγ+CD8
T cells isolated CD3+ lymphocytes co-cultured with or without autologous NETs for 7 days in T1D patients (n = 7) evaluated by flow cytometry. Statistical analysis
was performed using a two-tailed Wilcoxon paired t-test and an unpaired t-test. Values of p < 0.05 (*), p < 0.01 (**) and p < 0.001 (***) were considered statistically
significant.
FIGURE 2 | Monocyte-derived dendritic cell functional analysis. (A) Representative histogram of the interaction between moDCs and autologous NETs dyed with
DAPI. (B) CD86, HLA-DR and PDL1 expression in the moDC co-cultured with or without autologous NET from 9 T1D patients (67% female) and 8 healthy donors
(62% female) detected by flow cytometry. (C) Cytokine production by moDCs from 7 T1D (57% female) and 8 healthy (62% female) donors co-cultured with or
without autologous NET analyzed by Luminex. (D) Radar graph displaying a shift between T cell populations induced by moDCs co-cultured with or without
autologous NET. Data are expressed as the median of the response index (% of cells cultured with NETs/% of cells cultured without NETs). T cell populations
analyzed by flow cytometry are defined as Th1 (IFNγ+CD4), Treg (FoxP3+CD25hiCD127-CD4) and IFNγ-producing CD8+ lymphocytes. (E) moDCs of 8 T1D (62%
female) and 5 healthy (60% female) donors were incubated with or without autologous NETs for 24 h, and then the L-lactate concentration in the culture supernatant
was measured as an indicator of glycolytic activity by ELISA. Statistical analysis was performed using a two-tailed Wilcoxon paired t-test and an unpaired t-test.
Values of p < 0.05 (*), p < 0.01 (**) and p < 0.001 (***) were considered statistically significant.
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after co-cultivation with NETs from both T1D patients and
healthy donors (Figure 1E).
To clarify the influence of other cellular populations, such as
professional antigen presenting myeloid (mDC) or plasmacytoid
dendritic cells (pDC) and monocytes, on T cell delineation, we
isolated CD3+ cells from PBMCs and co-cultivated them with
autologous NETs for 7 days. We did not observe any significant
changes in T cell populations under these conditions (Figure 1F),
suggesting a role for dendritic cells and monocytes in mediating
the biological effect of NETs in T1D.
Monocyte-Derived Dendritic Cells of T1D
Children Are Uniquely Responsive to
NETs
Due to the rarity of dendritic cells in peripheral blood, elucidating
their role in response to NETs required us to adopt the
monocyte-derived dendritic cells (moDCs) model. We thus
generated moDCs of healthy donors, as well as of T1D patients
from adherent monocytes. On day 6, immature dendritic cells
(iDCs) were harvested and matured by co-cultivation with
NET fragments, and interactions became apparent in some cells
within 1 h of co-culture (Figure 2A) and universal for all
iDCs within 5 h.
We observed no change in the iDC phenotype after 24 h of
autologous NET co-culture in healthy donors. On the other hand,
patient iDCs significantly upregulated their surface expression
of CD86, HLA-DR and surprisingly also PDL1 (Figure 2B).
This upregulation was mirrored by a significant increase in
IL-6, TNFα and IFNα production (Figure 2C), as well as an
increased glycolytic activity present in T1D but not healthy iDCs
(Figure 2E) co-cultured with NETs.
We verified the functional impact of these changes by co-
culturing the healthy as well as patients’ NET-matured moDCs
with autologous T cells. Patient NET-moDCs induced a very
strong IFNγ-producing T cells and fewer Tregs with significantly
lower CD25 expression compared to that of the healthy NET-
moDCs (Figure 2D and Supplementary Figures 1E–H).
NETs in T1D Patients Differ in
Composition and Are Rich in
DNA-Histone Complexes
To further characterize whether the observed proinflammatory
profile of moDC after NET exposure in T1D patients was caused
by properties of NETs or by inherently altered functions of patient
moDCs, we investigated NET composition. The composition of
NETs varied in the T1D patients from the healthy donors. Patient
NETs contained significantly more DNA-histone complexes
(Figure 3A) and neutrophil elastase (NE) (Figure 3B) but less
myeloperoxidase (MPO) (Figure 3C) and LL37 (Figure 3D).
Interestingly, when we tested DNaseI concentration in the serum
of T1D patients and healthy donors as a marker of NET digestion
and regulation of inflammation, T1D patients had higher DNaseI
levels than did the healthy donors (Supplementary Figure 1I).
Overall, we observed a significant shift toward DNA-histones
and NE and away from the NET-associated proteins MPO and
LL37 in the T1D patient NETs, but we observed no correlation
FIGURE 3 | NET-associated product quantification in neutrophil extracellular
traps. (A) Levels of histone-associated DNA fragments, (B) neutrophil elastase
(NE), (C) myeloperoxidase (MPO) and (D) LL37 in NET fragments of T1D
patients (56–65% female) and healthy donors (56–68% female), detected by
ELISAs were analyzed in 14, 29 or 38 T1D patients and 14, 20 or 30 HD
respectively. Statistical analysis was performed using unpaired t-tests. Values
of p < 0.01 (**) were considered statistically significant.
of NET composition with age, HbA1c, age at diagnosis, or T1D
duration (data not shown).
T1D NETs Can Induce a Diabetogenic
Signature in Healthy moDC
Even though we observed that T1D NETs displayed altered
composition, we proceed to further characterize potential
inherently amended functions of patients’ moDCs. We
stimulated healthy moDCs with heterologous T1D-NETs or
with autologous HD-NETs and did the same for T1D-moDCs
(stimulated with autologous T1D-NETs or with heterologous
HD-NETs) and then analyzed their transcriptomic profile.
Firstly, we noted different gene profiles between unstimulated
HD-moDC and unstimulated T1D-moDC (Supplementary
Figures 2A,B) with 1568 DEGs (differently expressed genes).
Pathway enrichment analysis performed with ENRICHR
(29, 30) drawing on the HumanCyc (31) curated database
revealed that the highest enriched pathways include metabolic
processes such as glycolysis or gluconeogenesis (Supplementary
Figure 2D). Further dysregulation in the immune system and
in particular signal transduction was revealed by Reactome
(Supplementary Figure 2C).
Next, we compared healthy HD-moDCs stimulated with
autologous HD-NETs against HD-moDCs stimulated with
heterologous T1D-NETs. 302 genes were differentially expressed
between those two conditions (Figures 4A,B), and these genes
showed that HD-NET-stimulated HD-moDC cluster together
with unstimulated HD-moDC, as opposed to T1D-NET-
stimulated HD-moDC.
The Wikipathway analysis (32) showed the top dysregulated
pathways included TGFβ and IL-6 signaling due to the
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FIGURE 4 | Analysis of RNA-Seq data from HD moDCs stimulated with autologous NETs versus HD moDCs stimulated with heterologous T1D NETs. (A) Cluster
analysis of HD unstimulated moDCs, stimulated with autologous NETs and heterologous NETs. (B) principal component analysis (PCA) of HD and T1D moDCs
stimulated with autologous NETs or heterologous T1D NETs (C). WikiPathways analysis of enriched pathways involved in moDC after NET stimulation (D) and (E)
relative expression of enriched genes involved in TGFβ and IFNα signaling (F) GSEA (gene set enrichment analysis) of created a T1D signature gene set containing
1568 DEGs that were differentially expressed between unstimulated healthy moDCs and unstimulated T1D moDCs, divided into those that were upregulated and
downregulated in T1D compared to HD. moDC from healthy donor (n = 5) (40% female) were cultivated with autologous healthy NETs (HD-NETs), heterologous
T1D-NETs or left untreated for 24 h and their (G) phenotype determined by flow cytometry and (H) cytokine production analyzed by Luminex were evaluated.
Statistical analysis was performed using unpaired t-tests. Values of p < 0.05 (*) and p < 0.01 (**) were considered statistically significant.
involvement of genes such as WNT1, EID2, SKIL, SPP1 and
TGIF1 (Figures 4C,D). Expression of TGFβ related genes
was higher in HD-NET stimulated HD-moDCs, whereas
stimulation with T1D-NETs upregulated genes involved in IFNα
signaling (with involvement of genes SOCS3, PIK3R1, STAT2)
(Figures 4D,E) indicating that T1D-NETs induce a loss of
tolerogenicity and proinflammatory IFNα response. We further
illustrate this proinflammatory diabetogenic activity of T1D-
NETs with a PCA (principal component analysis) analysis of the
302 DEGs, which grouped T1D moDC samples with healthy
moDC treated with T1D-NETs, whereas HD-NET-stimulated
HD-moDCs formed a separate cluster (Figure 4B).
To prove that T1D-NETs indeed drive a shift in HD-moDCs
toward the transcriptomic profile of moDC of diabetic patients
we created a T1D signature gene set containing 1568 DEGs
that were differentially expressed between unstimulated healthy
moDCs and unstimulated T1D moDCs, divided into those
that were upregulated and downregulated in T1D compared to
HD. Gene set enrichment analysis (GSEA) revealed significant
enrichment (p = 0.0175, enrichment score 0.64) of the T1D-
upregulated genes in T1D-NET-stimulated HD-moDCs. When
healthy moDCs were treated with their own healthy NETs, there
was no significant enrichment of this gene set (p = 0.051 and
enrichment score 0.56) (Figure 4F).
Additionally, we also analyzed changes in phenotype and
cytokine production in healthy moDCs upon exposure to
hetelogous T1D-NETs and found out that HD-moDCs expressed
significantly higher level of CD86, HLA-DR, PDL1 and
produced markedly more proinflammatory cytokines under these
conditions (Figures 4G,H).
DISCUSSION
NETs have recently become a hot topic for research due to
their proposed role in the development of autoimmune diseases.
In our study, we investigated the biological impact of NETs
in a complex model of immune reactions in T1D patients.
A Th1-skewed T cell response has been traditionally shown
in T1D (33, 34), but has not yet been linked to a specific
innate biological activity. Here, we show that NETs from
T1D patients but not healthy controls induce IFNγ-producing
CD4 and CD8 T cells, supporting the notion that it may be
the presence of NETs in pancreatic tissue that stimulate the
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well-established downstream cascade of adaptive immune cell
activation (14).
Our data showed that this induction of IFNγ-producing
T cells does not arise from the direct effect of NETs on
T cells, but is mediated through other cell populations. In
the search for the cells responsible for the observed effect
we have expanded our findings by adopting the monocyte-
derived DC model (moDC), which allowed us to explore
the rare population of dendritic cells, the primary inducers
of T cell activation. In contrast to healthy moDCs that
showed no reaction to NETs (35, 36), T1D patient moDCs
reacted to NET fragments vigorously through a significant
increase in their maturation markers, inflammatory cytokine
production including the secretion of IFNα, as well as by their
capacity to induce IFNγ-producing T lymphocytes. The NET-
stimulated T1D moDCs also switched to anaerobic glycolysis,
as documented by the increase in L-lactate levels, further
corroborating their proinflammatory state (37, 38). Together,
these results show different qualities of DCs in T1D patients
in their reactivity to NETs, which again might support the idea
that the T cell pancreatic infiltration may be promoted via NET-
driven DC activation.
Intrigued by the observed proinflammatory response of T1D
moDC to NETs, we decided to investigate further whether the
profile is caused by inherent moDC properties or by the quality
and composition of NETs themselves. While substantial evidence
has been gathered on hyperglycemia promoting steady state
but decreasing inducible NET formation, which in turn impairs
wound healing in both type 1 and type 2 diabetes (15–17), it is
still unclear whether T1D patient-derived NETs are inherently
different from those of their healthy counterparts. In this study
we observed decreased levels of antimicrobial peptides, MPO and
LL37 in T1D NETs and additionally uncovered a strong shift
toward histone-associated DNA fragments compared to healthy
NETs. Particular histone modifications are an increasingly
recognized quality of NETs influencing both the process of
NET release itself and NET effect on numerous diseases (39),
and observed differences in NET composition in T1D patients
might strongly influence their biological activity, including
their contribution to T1D development and progression. Since
NETs in general are a source of autoantigens (40) they may
contain islet autoantigens in T1D patients, which in turn
would be processed by dendritic cells and further elicit both
specific B cell and T cell responses (41). Potential capture
of T1D autoantigens by neutrophils and their further release
in NETs potentiating diabetogenic immune response is an
intruiquing, however, as of yet unproven possibility. T1D patients
display minor but not negligible neutropenia (42). Together
with diminished levels of important antimicrobial peptides in
NET structures, T1D patients might exhibit worsen defense
against infections.
However, NET composition is not alone in its impact
on the proinflammatory response our study describes.
T1D PBMCs are known to harbor a distinct expression
pattern of genes related to inflammatory response, fatty acid
biosynthesis, hydrolase activity, lipid peroxidation and cell
metabolism (43–45), which we were able to confirm also in
our experimental model. Of note, we derived a prodiabetogenic
signature from genes that were differentially expressed in
T1D moDCs and transcriptome analysis newly revealed
that even though T1D moDCs already carry altered steady
state properties, T1D NETs but not healthy donor-derived
NETs are uniquely able to induce a this prodiabetogenic
signature in healthy moDCs. Thus, our data agree with the
current hypothesis that both intrinsic factors, such as altered
metabolic state of cells, as well as altered effect of T1D NETs,
have an important role in the induction of proinflammatory
profile of T1D moDC.
In summary, we show that NETs from T1D patients have
different composition compared to those of healthy donors
and induce different response in immune cells illustrated here
in a model of monocyte-derived dendritic cells as well as
directly in ex vivo peripheral blood PBMCs. T1D NETs promote
activation, phenotypic changes, increased cytokine release and
metabolic shift toward glycolysis compared to healthy NETs,
and their addition to cell culture also drives T cell polarization
toward IFNγ-producing CD4 and CD8 cells. These findings
support the important role of neutrophils and NETs in the
pathogenesis of T1D and identify another critical connection
between the innate and adaptive immunity in T1D pathogenesis.
Thus, we suggest that formation of NETs may be involved
in triggering a proinflammatory response in myeloid cells,
which in turn initiate a T cell-mediated immune response.
Our work provides the basis for future studies which will
test whether the observed proinflammatory NET properties
derived from T1D patients are also present prior to the
disease onset. Such intrinsic abnormalities might thus establish
the NETs as active players in T1D development. To our
knowledge this is the first study describing the distinct protein
content in T1D NETs.
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24. Dáňová K, Klapetková A, Kayserová J, Šedivá A, Špíšek R, Jelínková LP. NF-
κB, p38 MAPK, ERK1/2, mTOR, STAT3 and increased glycolysis regulate
stability of paricalcitol/dexamethasone- generated tolerogenic dendritic cells
in the inflammatory environment. Oncotarget. (2015) 6:14123–38. doi: 10.
18632/oncotarget.4234
25. Martin M. Cutadapt removes adapter sequences from high-throughput
sequencing reads. EMBnet J. (2011) 17:10. doi: 10.14806/ej.17.1.200
26. Trapnell C, Roberts A, Goff L, Pertea G, Kim D, Kelley DR, et al. Differential
gene and transcript expression analysis of RNA-seq experiments with TopHat
and Cufflinks. Nat Protoc. (2012) 7:562–78. doi: 10.1038/nprot.2012.016
27. Anders S, Pyl PT, Huber W. HTSeq–a Python framework to work with high-
throughput sequencing data. Bioinformatics. (2015) 31:166–9. doi: 10.1093/
bioinformatics/btu638
28. Westfall PH, Young SS. Resampling-Based Multiple Testing: Examples
and Methods for P-Value Adjustment. Wiley. (1993). Available online
at: https://www.wiley.com/en-us/Resampling+Based+Multiple+Testing:
+Examples+and+Methods+for+p+Value+Adjustment-p-9780471557616
(accessed May 26, 2019).
Frontiers in Immunology | www.frontiersin.org 8 April 2020 | Volume 11 | Article 661
fimmu-11-00661 April 13, 2020 Time: 14:29 # 9
Parackova et al. DC Response to NETs in T1D
29. Chen EY, Tan CM, Kou Y, Duan Q, Wang Z, Meirelles G, et al. Enrichr:
interactive and collaborative HTML5 gene list enrichment analysis tool. BMC
Bioinformatics. (2013) 14:128. doi: 10.1186/1471-2105-14-128
30. Kuleshov MV, Jones MR, Rouillard AD, Fernandez NF, Duan Q, Wang Z,
et al. Enrichr: a comprehensive gene set enrichment analysis web server 2016
update. Nucleic Acids Res. (2016) 44:W90–7. doi: 10.1093/nar/gkw377
31. Romero P, Wagg J, Green ML, Kaiser D, Krummenacker M, Karp PD.
Computational prediction of human metabolic pathways from the complete
human genome. Genome Biol. (2004) 6:R2. doi: 10.1186/gb-2004-6-1-r2
32. Slenter DN, Kutmon M, Hanspers K, Riutta A, Windsor J, Nunes N, et al.
WikiPathways: a multifaceted pathway database bridging metabolomics to
other omics research. Nucleic Acids Res. (2018) 46:D661–7. doi: 10.1093/nar/
gkx1064
33. Katz JD, Benoist C, Mathis DT. Helper cell subsets in insulin-dependent
diabetes. Science. (1995) 268:1185–8. doi: 10.5194/acp-14-1587-2014
34. Arif S, Tree TI, Astill TP, Tremble JM, Bishop AJ, Dayan CM, et al.
Autoreactive T cell responses show proinflammatory polarization in diabetes
but a regulatory phenotype in health. J Clin Invest. (2004) 113:451–63. doi:
10.1172/JCI200419585.Introduction
35. Barrientos L, Bignon A, Gueguen C, de Chaisemartin L, Gorges R, Sandré C,
et al. Neutrophil extracellular traps downregulate lipopolysaccharide-induced
activation of monocyte-derived dendritic cells. J Immunol. (2014) 193:5689–
98. doi: 10.4049/jimmunol.1400586
36. Sabbione F, Keitelman IA, Iula L, Ferrero M, Giordano MN, Baldi P, et al.
Neutrophil extracellular traps stimulate proinflammatory responses in human
airway epithelial cells. J Innate Immun. (2017) 9:387–402. doi: 10.1159/
000460293
37. Loftus RM, Finlay DK. Immunometabolism: cellular metabolism turns
immune regulator. J Biol Chem. (2016) 291:1–10. doi: 10.1074/jbc.R115.
693903
38. Bajwa G, DeBerardinis RJ, Shao B, Hall B, Farrar JD, Gill MA. Cutting
edge: critical role of glycolysis in human plasmacytoid dendritic cell antiviral
responses. J Immunol. (2016) 196:2004–9. doi: 10.4049/jimmunol.1501557
39. Hamam HJ, Palaniyar N. Post-translational modifications in NETosis
and NETs-mediated diseases. Biomolecules. (2019) 9:369. doi: 10.3390/
biom9080369
40. Khandpur R, Carmona-rivera C, Vivekanandan-giri A, Yalavarthi S, Knight
JS, Friday S, et al. NETs are a source of citrullinated autoantigens and
stimulate inflammatory responses in rheumatoid arthritis. Sci Transl Med.
(2013) 5:178ra40. doi: 10.1126/scitranslmed.3005580.NETs
41. Clark M, Kroger CJ, Tisch RM. Type 1 diabetes: a chronic anti-self-
inflammatory response. Front Immunol. (2017) 8:1898. doi: 10.3389/fimmu.
2017.01898
42. Valle A, Giamporcaro GM, Scavini M, Stabilini A, Grogan P, Bianconi
E, et al. Reduction of circulating neutrophils precedes and accompanies
type 1 diabetes. Diabetes. (2013) 62:2072–7. doi: 10.2337/DB1
2-1345
43. Mastracci TL, Turatsinze J-V, Book BK, Restrepo IA, Pugia MJ, Wiebke EA,
et al. Distinct gene expression pathways in islets from individuals with short-
and long-duration type 1 diabetes. Diabetes Obes Metab. (2018) 20:1859–67.
doi: 10.1111/dom.13298
44. Ozsari L, Karadurmus N, Sahin M, Uckaya G, Ural AU, Kutlu M. Comparison
of lymphomononuclear cell energy metabolism between healthy, impaired
glucose intolerance and type 2 diabetes mellitus patients. Endocrine. (2010)
37:135–9. doi: 10.1007/s12020-009-9281-0
45. Kaizer EC, Glaser CL, Chaussabel D, Banchereau J, Pascual V, White PC. Gene
expression in peripheral blood mononuclear cells from children with diabetes.
J Clin Endocrinol Metab. (2007) 92:3705–11. doi: 10.1210/jc.2007-0979
46. Parackova Z, Zentsova I, Klocperk A, Vrabcova P, Sumnik Z, Pruhova S, et al.
Posters. Eur J Clin Invest. (2019) 49:101–221. doi: 10.1111/eci.13109
Conflict of Interest: The authors declare that the research was conducted in the
absence of any commercial or financial relationships that could be construed as a
potential conflict of interest.
Copyright © 2020 Parackova, Zentsova, Vrabcova, Klocperk, Sumnik, Pruhova,
Petruzelkova, Hasler and Sediva. This is an open-access article distributed under the
terms of the Creative Commons Attribution License (CC BY). The use, distribution
or reproduction in other forums is permitted, provided the original author(s) and
the copyright owner(s) are credited and that the original publication in this journal
is cited, in accordance with accepted academic practice. No use, distribution or
reproduction is permitted which does not comply with these terms.
Frontiers in Immunology | www.frontiersin.org 9 April 2020 | Volume 11 | Article 661
